Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR-DEBIRI: DEBIRI + Chemo in CRC Liver Mets
NCT06555003Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irinotecan in colorectal cancer (CRC), sponsored by Tehran University of Medical Sciences. Started Jan 2025; status: recruiting.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06555003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06555003.